18F-FDG PET/CT 鉴别腹膜后纤维化与恶性模仿病变的价值
iRPF 高 FDG 摄取病灶频率更低(P=0.017),平均 SUVmax 更低(P<0.001);SUVmax 的 AUC 为 0.893,联合模型 AUC 达 0.987。
要点
- iRPF 与淋巴瘤形态学有差异,但与腹膜后转移癌形态学差异不显著。
- SUVmax 截断值 6.23 时鉴别灵敏度 85.7%、特异度 80.3%。
- 联合肾动脉以上病灶、SUVmax 和特异性淋巴结数的模型鉴别效能更高。
核心结论
- 腹膜后恶性肿瘤可在形态上模仿 iRPF,18F-FDG PET/CT 有助于区分 iRPF 与腹膜后淋巴瘤及转移性恶性肿瘤。
主要发现
- iRPF 与淋巴瘤在形态学特征上差异显著,但与腹膜后转移癌形态学差异不显著。
- 与恶性肿瘤相比,iRPF 高 FDG 摄取腹膜后病灶频率更低(P=0.017),平均 SUVmax 更低(P<0.001)。
- 腋窝、腹膜后、锁骨上、腹股沟或腹膜部位淋巴结在腹膜后恶性肿瘤中更常见,被定义为特异性淋巴结。
- SUVmax 的 AUC 为 0.893,截断值 6.23 时灵敏度 85.7%、特异度 80.3%。
- 联合肾动脉以上病灶、SUVmax 和特异性淋巴结数的 logistic 回归模型 AUC 为 0.987,灵敏度 90.5%、特异度 98.6%。
关键数值与推荐
- SUVmax 截断值 6.23 用于鉴别 iRPF 与腹膜后恶性肿瘤,灵敏度 85.7%、特异度 80.3%,AUC 0.893。
- 联合模型(肾动脉以上病灶+SUVmax+特异性淋巴结数)AUC 0.987,灵敏度 90.5%、特异度 98.6%。
- 风险分层模型分析显示多数腹膜后恶性肿瘤患者处于中或高风险,多数 iRPF 患者处于低风险。
临床怎么用
- 对疑似 iRPF 患者可行 18F-FDG PET/CT 评估病灶 FDG 摄取及淋巴结分布,辅助与腹膜后恶性肿瘤鉴别。
- 可参考 SUVmax 截断值 6.23 及联合模型要素(肾动脉以上病灶、SUVmax、特异性淋巴结数)进行风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To discuss the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) in the diagnosis of idiopathic retroperitoneal fibrosis (iRPF). METHODS: IRPF patients diagnosed between September 2011 and June 2016 were included. Retroperitoneal malignancy patients were included as control. The morphological features and FDG uptake of retroperitoneal lesions were measured along with lymph node (LN) mapping. RESULTS: Seventy-one iRPF patients were included. Fifteen lymphoma patients and 6 retroperitoneal metastatic malignancy patients were included as control. Significant differences in morphological features were observed between iRPF and lymphoma but not retroperitoneal metastatic carcinoma. Compared with malignancy, iRPF displayed a lower frequency of high-FDG-uptake retroperitoneal lesions (P = 0.017) and a lower mean maximum standardized uptake value (SUVmax) (P < 0.001). LNs located at axillary, retroperitoneal, supraclavicular, inguinal or peritoneal sites were more frequently observed in retroperitoneal malignancy, therefore, were defined as specific LNs. The area under the curve (AUC) for SUVmax was 0.893 with a sensitivity of 85.7% and a specificity of 80.3%, when the cut-off value of the SUVmax was 6.23. The AUC for the logistic regression model combining the lesions above renal arteries, the SUVmax and the number of specific LNs was 0.987 with a sensitivity of 90.5% and a specificity of 98.6%. The risk stratification model analysis indicated that most of the retroperitoneal malignancy patients were at moderate or high level, while most of the iRPF patients were at low risk. CONCLUSIONS: Retroperitoneal malignancy can mimic iRPF morphologically. 18F-FDG PET/CT can help to distinguish iRPF from retroperitoneal lymphoma and metastatic malignancy.
引用
- Wang Y, Guan Z, Gao D, et al. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum. 2017. PMID: 28958769. doi:10.1016/j.semarthrit.2017.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。